应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09939 开拓药业-B
未开盘 07-22 16:08:56
1.030
+0.000
0.00%
最高
1.100
最低
1.000
成交量
13.80万
今开
1.100
昨收
1.030
日振幅
9.71%
总市值
4.61亿
流通市值
4.61亿
总股本
4.47亿
成交额
14.07万
换手率
0.03%
流通股本
4.47亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
突发!500亿元医药巨头,董事长辞职
中国基金报 · 00:12
突发!500亿元医药巨头,董事长辞职
万春医药下跌3.68%,报2.119美元/股
金融界 · 07-22 23:52
万春医药下跌3.68%,报2.119美元/股
CXO、医疗设备联袂拉涨,医疗ETF(512170)逆市斩获四连阳!公募基金医药持仓降至冰点,机构:有望企稳回升
新浪基金 · 07-22 21:26
CXO、医疗设备联袂拉涨,医疗ETF(512170)逆市斩获四连阳!公募基金医药持仓降至冰点,机构:有望企稳回升
辉瑞中国区总裁、RDPAC执行委员会主席彭振科:加强与中国本土企业和科研机构的合作,促进全球医药产业链整合
每日经济新闻 · 07-22 20:45
辉瑞中国区总裁、RDPAC执行委员会主席彭振科:加强与中国本土企业和科研机构的合作,促进全球医药产业链整合
同源康医药通过上市聆讯:两年亏7亿 公司估值超30亿
雷递网 · 07-22 17:23
同源康医药通过上市聆讯:两年亏7亿 公司估值超30亿
恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%
金吾财讯 · 07-22 16:23
恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%
7月22日药康生物涨5.98%,天弘医药创新A基金重仓该股
证券之星 · 07-22 16:03
7月22日药康生物涨5.98%,天弘医药创新A基金重仓该股
龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情
格隆汇 · 07-22 14:44
龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情
浙江同源康医药通过港交所主板上市聆讯 建立11款候选药物管线
观点地产网 · 07-22 11:33
浙江同源康医药通过港交所主板上市聆讯 建立11款候选药物管线
新股消息丨同源康医药通过港交所聆讯 已建立由11款候选药物组成的管线
智通财经 · 07-22 11:09
新股消息丨同源康医药通过港交所聆讯 已建立由11款候选药物组成的管线
医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善
金吾财讯 · 07-22 10:40
医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善
开拓药业-B盘中异动 股价大涨6.89%报1.101港元
自选股智能写手 · 07-22 09:30
开拓药业-B盘中异动 股价大涨6.89%报1.101港元
药易购新注册《药易购医药批发平台V6.0.0》项目的软件著作权
证券之星 · 07-22 01:15
药易购新注册《药易购医药批发平台V6.0.0》项目的软件著作权
【兴证医药】一图速览2024Q2公募基金A股医药/港股医药持仓变化
兴证医药健康 · 07-21 16:29
【兴证医药】一图速览2024Q2公募基金A股医药/港股医药持仓变化
国家队重仓了哪些医药股?
财经杂志 · 07-21 15:41
国家队重仓了哪些医药股?
兴证策略:基金二季报的七大看点
格隆汇 · 07-21 09:38
兴证策略:基金二季报的七大看点
君科臻元公布天使+融资,投资方为海南科瑞鸿泰基金、元生创投等
证券之星 · 07-20 19:28
君科臻元公布天使+融资,投资方为海南科瑞鸿泰基金、元生创投等
18A市值半年考!君圣泰、圣诺医药跌幅近九成,科伦博泰、复宏汉霖、亚盛医药涨幅前三
医药经济报 · 07-20 13:31
18A市值半年考!君圣泰、圣诺医药跌幅近九成,科伦博泰、复宏汉霖、亚盛医药涨幅前三
万春医药下跌7.13%,报2.145美元/股
金融界 · 07-19
万春医药下跌7.13%,报2.145美元/股
国信证券:二季度公募基金港股配置明显提升 电子、医药以及食品饮料配置权重最高
智通财经 · 07-19
国信证券:二季度公募基金港股配置明显提升 电子、医药以及食品饮料配置权重最高
加载更多
公司概况
公司名称:
开拓药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。
发行价格:
--
{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":1.03,"timestamp":1721635736037,"preClose":1.03,"halted":0,"volume":138000,"delay":0,"floatShares":447499600,"shares":447499600,"eps":-2.6457136,"marketStatus":"未开盘","marketStatusCode":0,"change":0,"latestTime":"07-22 16:08:56","open":1.1,"high":1.1,"low":1,"amount":140735,"amplitude":0.097087,"askPrice":1.03,"askSize":27500,"bidPrice":1.02,"bidSize":30000,"shortable":0,"etf":0,"ttmEps":-2.645713521801928,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1590076800000,"adjPreClose":1.03,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.292745,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2453790621","title":"突发!500亿元医药巨头,董事长辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2453790621","media":"中国基金报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453790621?lang=zh_cn&edition=full","pubTime":"2024-07-23 00:12","pubTimestamp":1721664751,"startTime":"0","endTime":"0","summary":"掌舵近11年突然离职7月22日,白云山董事会收到其董事长李楚源递交的书面辞职报告。其中,李楚源自2010年6月28日起任白云山副董事长,2013年8月8日起任白云山董事长,截至目前,李楚源已经掌舵白云山接近11年。李楚源的突然辞职,未导致白云山董事会成员人数低于法定最低人数,但仍需有人代为履行董事长职责。2023年、2024年第一季度,白云山分别实现归母净利润40.56亿元、19.58亿元,分别同比增长2.25%、2.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072300145795502e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072300145795502e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09939","00874","BK1161","BK1606","BK1197","BK1515","BK1574","BK1521"],"gpt_icon":0},{"id":"2453797090","title":"万春医药下跌3.68%,报2.119美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453797090","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453797090?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:52","pubTimestamp":1721663573,"startTime":"0","endTime":"0","summary":"7月22日,万春医药(BYSI)盘中下跌3.68%,截至23:52,报2.119美元/股,成交9249.0美元。财务数据显示,截至2023年12月31日,万春医药收入总额175.1万美元,同比增长29.61%;归母净利润-2102.6万美元,同比增长36.82%。大事提醒:7月29日,万春医药将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/22235241723691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["159938","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2453798659","title":"CXO、医疗设备联袂拉涨,医疗ETF(512170)逆市斩获四连阳!公募基金医药持仓降至冰点,机构:有望企稳回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2453798659","media":"新浪基金","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453798659?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:26","pubTimestamp":1721654760,"startTime":"0","endTime":"0","summary":"今日医疗板块再度走出独立行情,中证医疗指数逆市收涨0.83%斩获五连阳,止跌企稳迹象愈发明显。截至收盘,中证医疗指数近10个交易日内有8日收涨。 ETF方面,医疗ETF跟踪复制中证医疗指数表现,今日盘中最高涨逾1.6%,午后涨幅收窄,场内价格收涨0.67%录得四连阳,全天成交3.87亿元。 值得关注的是,二季度公募基金医药持仓占比已降至五年低位。该机构认为,两项数据均已降至五年低位,有望企稳回升。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-07-22/doc-incezkfv4390399.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-07-22/doc-incezkfv4390399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159828","BK1574","BK1515","512170","CXO","BK1161","159873","159938","09939"],"gpt_icon":0},{"id":"2453677457","title":"辉瑞中国区总裁、RDPAC执行委员会主席彭振科:加强与中国本土企业和科研机构的合作,促进全球医药产业链整合","url":"https://stock-news.laohu8.com/highlight/detail?id=2453677457","media":"每日经济新闻","labels":["Policy And Regulatory"],"top":-1,"share":"https://www.laohu8.com/m/news/2453677457?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:45","pubTimestamp":1721652337,"startTime":"0","endTime":"0","summary":"7月22日,作为在中国工作了十多年的跨国外资制药企业负责人,辉瑞中国区总裁、RDPAC(中国外商投资企业协会药品研制和开发工作委员会)执行委员会主席Jean-ChristophePointeau(彭振科)认为,二十届三中全会聚焦高质量发展,强调科技创新和产业升级,与医药行业紧密相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407223137017410.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407223137017410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1023059063.AUD","BK4533","IE00B19Z3B42.SGD","LU0321505868.SGD","BK1574","BK4581","LU0456855351.SGD","LU1057294990.SGD","LU1894683348.USD","SG9999001176.SGD","BK4592","09939","SGXZ57979304.SGD","BK1161","IE00BLSP4239.USD","BK4007","SG9999002232.USD","LU1894683264.USD","LU0234572021.USD","PFE","SG9999001176.USD","SG9999013999.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999011175.SGD","BK4550","IE00BLSP4452.SGD","BK4585","LU0170899867.USD","LU0058720904.USD","LU0321505439.SGD","SG9999002224.SGD","BK4588","IE0002270589.USD","LU0289739699.SGD","BK1515","LU1066051498.USD","BK4568","BK4534","LU0868494617.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU1883839398.USD","LU0122379950.USD"],"gpt_icon":1},{"id":"2453751103","title":"同源康医药通过上市聆讯:两年亏7亿 公司估值超30亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2453751103","media":"雷递网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453751103?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:23","pubTimestamp":1721640187,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司(简称:“同源康医药”)日前通过聆讯,准备在港交所上市。同源康医药2024年7月初已通过中国证监会IPO备案,拿到了上市钥匙。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240722/6385726577317922075619560.png","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240722/6385726577317922075619560.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.leinews.com/n27224/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK1161","BK1574","BK1515","09939"],"gpt_icon":0},{"id":"2453755627","title":"恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453755627","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453755627?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:23","pubTimestamp":1721636605,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数震荡走强,收市均涨超1%,截至收盘,恒指涨1.25%,国企指数涨1.44%,恒生科技指数涨2.10%。全球电力需求的强劲增长将持续到2025年,届时增长率仍将达到4%左右。医药外包概念普涨,康龙化成涨6.43%,维亚生物涨5.05%,药明生物涨3.88%,泰格医药涨3.85%。个股方面,美团涨幅3.23%。中信国际电讯 跌21.35%。中信国际电讯公布,预期截至6月30日止六个月于报告期间录得公司股东应占溢利约4.55亿港元,较截至2023年6月30日止六个月期间减少约37%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NTRiNjliMWYyMDZiNDZkN2Y3NDQyNTQ0NjcxNTMyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRiNjliMWYyMDZiNDZkN2Y3NDQyNTQ0NjcxNTMyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","513600","LU0572940350.SGD","02833","159938","300759","BK1574","BK1583","03143","HHImain","LU0173614495.USD","LU0348814723.USD","BK1610","LU0463099449.HKD","LU2778985437.USD","HK0000320223.HKD","LU0348805143.USD","XIACY","LU0359201612.USD","LU1366334578.USD","01810","03968","BK1502","HSI","00992","03690","BK1575","03759","LNVGY","YANG","LU0231483743.USD","SG9999002562.SGD","LU0211977185.USD","MHImain","LU0501845795.SGD","MCHmain","09939","80992","81810","LU0791591158.USD","09961","01209","BK1576","LU0269904917.USD","LU0823426480.USD","HSImain","LU0348816934.USD","BK1559","00017","LU0348735423.USD","HK0000320264.USD"],"gpt_icon":1},{"id":"2453753420","title":"7月22日药康生物涨5.98%,天弘医药创新A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453753420","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453753420?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:03","pubTimestamp":1721635384,"startTime":"0","endTime":"0","summary":"证券之星消息,7月22日药康生物涨5.98%,收盘报10.98元,换手率2.58%,成交量5.27万手,成交额5747.4万元。重仓药康生物的公募基金请见下表:该股最近90天内共有14家机构给出评级,买入评级7家,增持评级7家;过去90天内机构目标均价为16.32。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为天弘医药创新A。天弘医药创新A目前规模为5.48亿元,最新净值0.6678,较上一交易日下跌0.21%,近一年下跌17.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200019341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK0216","09939","688046","BK1515","159938"],"gpt_icon":0},{"id":"2453731253","title":"龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2453731253","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453731253?lang=zh_cn&edition=full","pubTime":"2024-07-22 14:44","pubTimestamp":1721630654,"startTime":"0","endTime":"0","summary":"有望迎来边际改善","market":"sg","thumbnail":"https://img3.gelonghui.com/ace7d-6b3066d4-036c-4224-b3e3-aa509104a112.jpg?guru_height=812&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/ace7d-6b3066d4-036c-4224-b3e3-aa509104a112.jpg?guru_height=812&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/870710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0043850808.USD","LU1242518857.USD","BK1515","LU0359201612.USD","BK1610","LU2045819591.USD","LU0819121731.USD","LU0039217434.USD","06821","LU1720050803.USD","LU0307460666.USD","BK1141","BK0216","LU2125910500.SGD","LU0181495838.USD","02359","BK1191","SG9999002562.SGD","LU0516423174.USD","LU1046422090.SGD","03759","LU0823426308.USD","01873","03347","LU0572944931.SGD","SG9999002463.SGD","BK1574","LU0326950275.SGD","LU0052750758.USD","BK1576","LU0051755006.USD","LU0516423091.SGD","LU0708995583.HKD","BK1521","02269","LU0588546209.SGD","301333","09939","LU0823426480.USD","603127","LU0348825331.USD","LU0348735423.USD","BK1589","LU0456827905.SGD","LU0516422952.EUR","LU0979878070.USD","LU1880383366.USD","LU1794554557.SGD","LU2242644610.SGD","BK1583"],"gpt_icon":0},{"id":"2453278220","title":"浙江同源康医药通过港交所主板上市聆讯 建立11款候选药物管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2453278220","media":"观点地产网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453278220?lang=zh_cn&edition=full","pubTime":"2024-07-22 11:33","pubTimestamp":1721619180,"startTime":"0","endTime":"0","summary":"观点网讯:7月22日,浙江同源康医药股份有限公司(同源康医药)成功通过香港交易所主板上市聆讯。该公司已建立由11款候选药物组成的管线。中信证券担任此次上市的独家保荐人。同源康医药是一家生物医疗领域的公司,主要从事创新药物的研发。此次通过港交所主板上市聆讯,标志着公司在资本市场迈出了重要一步。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/estate/integration/2024-07-22/doc-inceypai1537588.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2024-07-22/doc-inceypai1537588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2453784927","title":"新股消息丨同源康医药通过港交所聆讯 已建立由11款候选药物组成的管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2453784927","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453784927?lang=zh_cn&edition=full","pubTime":"2024-07-22 11:09","pubTimestamp":1721617772,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据港交所7月22日消息,浙江同源康医药股份有限公司 通过港交所主板上市聆讯,中信证券为独家保荐人。自2017年成立以来,公司已建立由11款候选药物组成的管线,包括核心产品TY-9591、六款临床阶段产品及四款临床前阶段产品。财务方面,2022年、2023年及截至2024年3月31日止三个月,同源康医药研发成本分别约为人民币2.30亿元、2.49亿元、6469.9万元,年内╱期内亏损分别约为3.12亿元、3.83亿元、1.08亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","09939","BK1574","159938"],"gpt_icon":0},{"id":"2453891127","title":"医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2453891127","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453891127?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:40","pubTimestamp":1721616006,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普涨,截至发稿,康龙化成 涨6.66%,维亚生物涨5.05%,泰格医药涨2.84%,药明生物涨2.77%。该行认为,CXO板块在经历业绩、估值双杀之后,有望迎来边际改善。方正证券认为,国内CXO企业正快步向新兴领域延伸,拓展新品类,并加快相关布局,希望承接全球相关产能需求,在未来五年的成长之路收获新增量。此外,头部企业康龙化成发布盈喜,截至2024年6月30日的半年度业绩预告。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NjUzMWVjZjQ5MDRjNGY2OWIzOTk1NmJhNzg4ZTIwMmI4MTQyOTUwMDc1MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjUzMWVjZjQ5MDRjNGY2OWIzOTk1NmJhNzg4ZTIwMmI4MTQyOTUwMDc1MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940780","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","BK1574","LU0516422440.USD","LU0417516902.SGD","LU0516423091.SGD","BK0216","09939","01873","300759","LU0417516738.SGD","BK1161","BK0183","BK0188","BK1141","LU1794554557.SGD","LU1880383366.USD","LU1688375341.USD","02269","BK1576","LU0051755006.USD","600958","LU0327786744.USD","SG9999002562.SGD","BK1610","BK1583","159938","LU0856984785.SGD","LU0456827905.SGD","LU0043850808.USD","LU0359201612.USD","LU2039709279.SGD","SG9999002463.SGD","03958","LU0823426480.USD","LU0052750758.USD","BK1147","LU0320764599.SGD","LU0348735423.USD","LU0819121731.USD","LU0516423174.USD","LU0979878070.USD","BK1521","03759","BK0276","LU0181495838.USD","LU0359202008.SGD","BK1589","LU0348825331.USD","LU0823426308.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2453882237","title":"开拓药业-B盘中异动 股价大涨6.89%报1.101港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453882237","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453882237?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611832,"startTime":"0","endTime":"0","summary":"2024年07月22日早盘09时30分,开拓药业-B股票出现波动,股价大幅上涨6.89%。截至发稿,该股报1.101港元/股,成交量500股,换手率0.00%,振幅0.00%。资金方面,该股资金流入550港元,流出0港元。开拓药业-B股票所在的药品行业中,整体涨幅为0.08%。其相关个股中,开拓药业-B、康龙化成、三生制药涨幅较大,振幅较大的相关个股有德琪医药-B、东瑞制药、康龙化成,振幅分别为6.15%、4.20%、1.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722093032af935100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722093032af935100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2453274126","title":"药易购新注册《药易购医药批发平台V6.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2453274126","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453274126?lang=zh_cn&edition=full","pubTime":"2024-07-22 01:15","pubTimestamp":1721582113,"startTime":"0","endTime":"0","summary":"证券之星消息,近日药易购(300937)新注册了《药易购医药批发平台V6.0.0》项目的软件著作权。今年以来药易购新注册软件著作权8个,较去年同期增加了700%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1932.07万元,同比增9.11%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200000211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK1515","159938","300937","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2453675094","title":"【兴证医药】一图速览2024Q2公募基金A股医药/港股医药持仓变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2453675094","media":"兴证医药健康","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453675094?lang=zh_cn&edition=full","pubTime":"2024-07-21 16:29","pubTimestamp":1721550540,"startTime":"0","endTime":"0","summary":"本公司并不对使用本报告所包含的材料产生的任何直接或间接损失或与此相关的其他任何损失承担任何责任。同时,本公司对本报告所含信息可在不发出通知的情形下做出修改,投资者应当自行关注相应的更新或修改。本公司没有将此意见及建议向报告所有接收者进行更新的义务。除非另有书面显示,否则本报告中的所有材料的版权均属本公司。任何完整的研究观点应以兴业证券股份有限公司正式发布的报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA4NjAxNzEzNw==&mid=2650184940&idx=1&sn=104dbd4dfe40fe933d858f97e38dca07&chksm=862391277cc8bcc5b123a6133de9579fa6aad02abbff7928b13ad095c57a8a27e3def9f4fe46&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1161","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2453759776","title":"国家队重仓了哪些医药股?","url":"https://stock-news.laohu8.com/highlight/detail?id=2453759776","media":"财经杂志","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453759776?lang=zh_cn&edition=full","pubTime":"2024-07-21 15:41","pubTimestamp":1721547660,"startTime":"0","endTime":"0","summary":"截至一季度末,国家队仍在加仓医药板块。国家队持股青睐药企把目光放长远,整体而言,医药仍是好的资产。据华泰证券,一季度,国家队仓位持续回升,加仓银行、医药、电子、基础化工等板块。截至一季度末,国家队持股的医药健康企业共104家,分布上相当广泛,约占医药健康股整体数量的五分之一。国家队持股比例第二位,是老牌药企华北制药,截至一季度末,占其总股本的9.03%。国家队目前持仓市值最高的医药企业,是恒瑞医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"weixin_highlight","url":"http://mp.weixin.qq.com/s?__biz=MjM5NDU5NTM4MQ==&mid=2653630473&idx=3&sn=59c82af66eb7340e13c5db685cbff07f&chksm=bc1735568a97613d8e6ca0aa2713e69b1be0e21e91038f981b97b535c646f51927066e427461&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5NDU5NTM4MQ==&mid=2653630473&idx=3&sn=59c82af66eb7340e13c5db685cbff07f&chksm=bc1735568a97613d8e6ca0aa2713e69b1be0e21e91038f981b97b535c646f51927066e427461&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1161","159938","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2453210530","title":"兴证策略:基金二季报的七大看点","url":"https://stock-news.laohu8.com/highlight/detail?id=2453210530","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453210530?lang=zh_cn&edition=full","pubTime":"2024-07-21 09:38","pubTimestamp":1721525923,"startTime":"0","endTime":"0","summary":"加仓科技成长、周期,减仓消费、医药","market":"hk","thumbnail":"https://img3.gelonghui.com/d38c4-549dfc73-5d45-4878-9b10-b86e5f0f2731.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d38c4-549dfc73-5d45-4878-9b10-b86e5f0f2731.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/868246","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4588","FDN","03189","BK4585","BK4550","83189","BK1161","BK1515","09939","BK1610","BK1574"],"gpt_icon":0},{"id":"2452239266","title":"君科臻元公布天使+融资,投资方为海南科瑞鸿泰基金、元生创投等","url":"https://stock-news.laohu8.com/highlight/detail?id=2452239266","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452239266?lang=zh_cn&edition=full","pubTime":"2024-07-20 19:28","pubTimestamp":1721474891,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于7月10日公布的信息整理,绍兴君科臻元医药科技有限公司公布天使+融资,融资额未披露,参与投资的机构包括海南科瑞鸿泰基金,元生创投。绍兴君科臻元医药科技有限公司的历史融资如下:绍兴君科臻元医药科技有限公司是一家医药研发生产商,公司主要经营:医学研究和试验发展;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广。数据来源:天眼查APP以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072000017267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2452556532","title":"18A市值半年考!君圣泰、圣诺医药跌幅近九成,科伦博泰、复宏汉霖、亚盛医药涨幅前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2452556532","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452556532?lang=zh_cn&edition=full","pubTime":"2024-07-20 13:31","pubTimestamp":1721453482,"startTime":"0","endTime":"0","summary":"截至7月19日中午,近半年来,总市值跌幅最大的十家企业分别是君圣泰医药、圣诺医药、健世科技、来凯医药、创胜集团、润迈德、康宁杰瑞制药、宜明昂科、德琪医药和兆科眼科。截至公告发布之日,圣诺医药仅赎回了20万美元。截至7月19日中午,科伦博泰、复宏汉霖、亚盛医药、欧康维视生物和东曜药业近半年总市值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407201333569f6fe90d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407201333569f6fe90d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02696","BK1161","BK1515","02257","BK1574","02511","06628","02105","09877","01875","06855"],"gpt_icon":0},{"id":"2452744804","title":"万春医药下跌7.13%,报2.145美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452744804","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452744804?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:16","pubTimestamp":1721398613,"startTime":"0","endTime":"0","summary":"7月19日,万春医药(BYSI)盘中下跌7.13%,截至22:16,报2.145美元/股,成交2.13万美元。财务数据显示,截至2023年12月31日,万春医药收入总额175.1万美元,同比增长29.61%;归母净利润-2102.6万美元,同比增长36.82%。大事提醒:7月29日,万春医药将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/19221641688061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["09939","159938","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2452947994","title":"国信证券:二季度公募基金港股配置明显提升 电子、医药以及食品饮料配置权重最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2452947994","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452947994?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:40","pubTimestamp":1721396443,"startTime":"0","endTime":"0","summary":"二季报中披露配置权重最高的三个行业为电子、医药以及食品饮料行业,配置的权重分别为15.4%、11.16%以及9.5%。普通股票型和偏股混合型基金港股仓位中位数分别为16.24%和13.23%,均较上一季度明显提升。普通股票型配置港股基金数量为201只,偏股混合型配置港股基金数量为1360只,普通股票型以及偏股混合型基金中配置港股的基金数量占比为52.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","IE00B031HW06.USD","159843","IE00B8L5B284.USD","07226","IE00BF5LJ272.USD","00700","IE0008369823.USD","LU0067412154.USD","BK1502","LU0051755006.USD","HSTECH","LU0072913022.USD","LU0052750758.USD","YANG","BK1608","LU0043850808.USD","LU0084288322.USD","BK1591","LU0048597586.USD","BK1516","09939","BK0188","HSCEI","IE00B031J352.USD","IE00B3M56506.USD","LU0054450605.USD","HK0000320264.USD","IE0032431581.USD","LU0029874905.USD","IE00B031HY20.USD","IE0009570106.USD","LU0096374516.USD","002736","IE00BGV7N243.SGD","HK0000320223.HKD","000807.SH","LU0106959298.USD","BK1521","BK1589","BK0183","LU0128522157.USD","IE00B8HQ1Z84.USD","LU0061477393.USD","159938","80700","BK1161","IE0008368411.USD","BK1517","BK1526"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":-0.0721},{"period":"1month","weight":-0.0636},{"period":"3month","weight":0.0729},{"period":"6month","weight":-0.2077},{"period":"1year","weight":-0.7268},{"period":"ytd","weight":-0.3681}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.058646},{"month":2,"riseRate":0.75,"avgChangeRate":0.213088},{"month":3,"riseRate":0.25,"avgChangeRate":0.062774},{"month":4,"riseRate":0.75,"avgChangeRate":0.545629},{"month":5,"riseRate":0.5,"avgChangeRate":0.006555},{"month":6,"riseRate":0.2,"avgChangeRate":-0.08997},{"month":7,"riseRate":0.6,"avgChangeRate":0.022172},{"month":8,"riseRate":0.25,"avgChangeRate":-0.047081},{"month":9,"riseRate":0,"avgChangeRate":-0.284122},{"month":10,"riseRate":0.25,"avgChangeRate":-0.084422},{"month":11,"riseRate":0.75,"avgChangeRate":0.089012},{"month":12,"riseRate":0.25,"avgChangeRate":-0.241375}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}